Items where authors include "Rutella, S."

Article

Subklewe, M., Rutella, S. orcid.org/0000-0003-1970-7375 and Curti, A. (2025) The immunotherapy landscape in AML: Defining knowledge gaps toward rational combinatorial strategies. Seminars in Hematology, 62 (3). pp. 209-217. ISSN 0037-1963

Tin, E. orcid.org/0000-0001-7838-0400, Rutella, S. orcid.org/0000-0003-1970-7375, Khatri, I. orcid.org/0009-0007-0571-4749 et al. (8 more authors) (2025) SOCS1 protects acute myeloid leukemia against allogeneic T cell–mediated cytotoxicity. Blood Cancer Discovery, 6 (3). pp. 217-232. ISSN 2643-3230

Tin, E. orcid.org/0000-0001-7838-0400, Khatri, I., Fang, K. orcid.org/0009-0001-6662-7872 et al. (7 more authors) (2025) Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapy. Journal for ImmunoTherapy of Cancer, 13 (4). e010684. ISSN 2051-1426

Mazziotta, F. orcid.org/0000-0002-6126-8719, Biavati, L. orcid.org/0000-0001-7870-5754, Rimando, J. et al. (13 more authors) (2024) CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia. Blood, 144 (11). pp. 1168-1182. ISSN 0006-4971

Vadakekolathu, J. orcid.org/0000-0002-2671-4285 and Rutella, S. orcid.org/0000-0003-1970-7375 (2024) Escape from T-cell–targeting immunotherapies in acute myeloid leukemia. Blood, 143 (26). pp. 2689-2700. ISSN 0006-4971

Lindsay, J.O. orcid.org/0000-0003-3353-9590, Hind, D. orcid.org/0000-0002-6409-4793, Swaby, L. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11 (3). ISSN 2050-4365

Lindsay, J.O., Hind, D. orcid.org/0000-0002-6409-4793, Swaby, E. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253

Ocadlikova, D. orcid.org/0000-0002-6976-4450, Lussana, F. orcid.org/0000-0002-6510-8616, Fracchiolla, N. et al. (18 more authors) (2023) Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study. British Journal of Haematology, 203 (4). pp. 637-650. ISSN 0007-1048

Rutella, S. orcid.org/0000-0003-1970-7375, Vadakekolathu, J., Mazziotta, F. et al. (18 more authors) (2022) Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia. Journal of Clinical Investigation, 132 (21). e159579. ISSN 0021-9738

Corradi, G., Bassani, B., Simonetti, G. orcid.org/0000-0001-6954-969X et al. (17 more authors) (2022) Release of IFNγ by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells. Clinical Cancer Research, 28 (14). pp. 3141-3155. ISSN 1078-0432

Pockley, A.G., Lindsay, J.O., Foulds, G.A. et al. (6 more authors) (2018) Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD Low Intensity Therapy Evaluation Study Investigators. Frontiers in Immunology, 9. 646. ISSN 1664-3224